Drug Watch.
- Published in:
- Formulary, 2002, v. 37, n. 12, p. 650
- Publication type:
- Article
Works matching IS 1082801X AND DT 2002 AND VI 37 AND IP 12
Results: 23
1
2
Humana's four-tier benefit design; What does it look like, and how has it been working?
- Published in:
- Formulary, 2002, v. 37, n. 12, p. 648
- Publication type:
- Article
3
McClellan outlines priorities.
- Published in:
- Formulary, 2002, v. 37, n. 12, p. 647
- Publication type:
- Article
4
Healthcare at the forerfront on federal, state levels.
- Published in:
- Formulary, 2002, v. 37, n. 12, p. 646
- By:
- Publication type:
- Article
5
Migraine therapy: balancing efficacy and safety with quality of life and cost.
- Published in:
- Formulary, 2002, v. 37, n. 12, p. 634
- By:
- Publication type:
- Article
6
Migraine therapy: balancing efficacy and safety with quality of life and cost.
- Published in:
- 2002
- By:
- Publication type:
- Journal Article
7
Ezetimibe: a novel cholesterol absorption inhibitor.
- Published in:
- 2002
- By:
- Publication type:
- Journal Article
8
Web-based education program uses patients to drive point-of-care drug decision-making.
- Published in:
- Formulary, 2002, v. 37, n. 12, p. 622
- Publication type:
- Article
9
Drotecogin alfa sustains survival long-term in severe sepsis patients.
- Published in:
- Formulary, 2002, v. 37, n. 12, p. 622
- Publication type:
- Article
10
Drug and Formulary Trends.
- Published in:
- Formulary, 2002, v. 37, n. 12, p. 627
- Publication type:
- Article
11
Eye on the Literature.
- Published in:
- Formulary, 2002, v. 37, n. 12, p. 624
- Publication type:
- Article
12
news in brief.
- Published in:
- Formulary, 2002, v. 37, n. 12, p. 623
- Publication type:
- Article
13
Ezetimibe.
- Published in:
- Formulary, 2002, v. 37, n. 12, p. 628
- By:
- Publication type:
- Article
14
Adverse reactions to drugs are culprits in many deaths and injuries for children under 2.
- Published in:
- Formulary, 2002, v. 37, n. 12, p. 614
- Publication type:
- Article
15
FDA actions in brief.
- Published in:
- Formulary, 2002, v. 37, n. 12, p. 612
- Publication type:
- Article
16
Atorvastatin trial ends early because of benefits to patients with lower cholesterol, hypertension.
- Published in:
- Formulary, 2002, v. 37, n. 12, p. 623
- Publication type:
- Article
17
Drug shortage update.
- Published in:
- Formulary, 2002, v. 37, n. 12, p. 616
- Publication type:
- Article
18
Brief reports: Other adverse events in the news.
- Published in:
- Formulary, 2002, v. 37, n. 12, p. 616
- Publication type:
- Article
19
Large-scale study finds no link between autism and MMR vaccine.
- Published in:
- Formulary, 2002, v. 37, n. 12, p. 616
- Publication type:
- Article
20
Safety labeling updates & new warnings.
- Published in:
- Formulary, 2002, v. 37, n. 12, p. 614
- Publication type:
- Article
21
First-time generic approvals.
- Published in:
- Formulary, 2002, v. 37, n. 12, p. 613
- Publication type:
- Article
22
New molecular entities/new biologies.
- Published in:
- Formulary, 2002, v. 37, n. 12, p. 608
- Publication type:
- Article
23
Pipeline preview.
- Published in:
- Formulary, 2002, v. 37, n. 12, p. 608
- Publication type:
- Article